Home
Leif Henry Bostad's picture

Leif Henry Bostad

Emeritus
  • E-mailleif.bostad@uib.no
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2023). Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years. European Urology Oncology (EUO). 8 pages.
  • Show author(s) (2023). Long-term follow-up of IgA nephropathy: clinicopathological features and predictors of outcomes. Clinical Kidney Journal (CKJ). 2514-2522.
  • Show author(s) (2022). Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up. Nephrology, Dialysis and Transplantation. 1183-1191.
  • Show author(s) (2022). Utilizing the MEST score for prognostic staging in IgA nephropathy. BMC Nephrology. 1-11.
  • Show author(s) (2022). A multiomics disease progression signature of low-risk ccRCC. Scientific Reports. 1-15.
  • Show author(s) (2021). The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma. Cytokine. 1-10.
  • Show author(s) (2021). AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease. Cancer Cell International. 12 pages.
  • Show author(s) (2020). The biological context of c-reactive protein as a prognostic marker in renal cell carcinoma: Studies on the acute phase cytokine profile. Cancers. 1-18.
  • Show author(s) (2020). Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC). Cancer Immunology and Immunotherapy. 1-12.
  • Show author(s) (2018). Tumour cell expression of interleukin 6 receptor a is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. The journal of pathology. Clinical research. 114-123.
  • Show author(s) (2018). Prognostic factors in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with severe glomerular sclerosis: a national registry-based cohort study. Pathology Research International. 1-7.
  • Show author(s) (2018). Prognosis and Histological Classification in Elderly Patients with ANCA-Glomerulonephritis: A Registry-Based Cohort Study. BioMed Research International. 8 pages.
  • Show author(s) (2018). National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival. European Urology Oncology (EUO). 252-261.
  • Show author(s) (2018). Impact of proteinase 3 versus myeloperoxidase positivity on risk of end-stage renal disease in ANCA-associated glomerulonephritis stratified by histological classification: A population-based cohort study. Disease Markers. 1-7.
  • Show author(s) (2018). Exploring sex-specific differences in the presentation and outcomes of ANCA-associated vasculitis: a nationwide registry-based cohort study. International Urology and Nephrology. 1311-1318.
  • Show author(s) (2017). Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. BMC Urology. 1-11.
  • Show author(s) (2017). Cancer in ANCA-associated glomerulonephritis: a registry-based cohort study. International Journal of Nephrology. 1-8.
  • Show author(s) (2016). Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study. Influenza and Other Respiratory Viruses. 525-531.
  • Show author(s) (2016). Prognostic value of histologic classification of ANCA-associated glomerulonephritis. American Society of Nephrology. Clinical Journal. 2159-2167.
  • Show author(s) (2016). Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients. Acta Oncologica. 349-356.
  • Show author(s) (2016). A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use. World Journal of Urology. 1087-1099.
  • Show author(s) (2015). Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma. Scandinavian Journal of Urology. 388-394.
  • Show author(s) (2015). Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma. Scandinavian Journal of Urology. 205-210.
  • Show author(s) (2014). Health-related quality of life in long-term survivors after renal cancer treatment. Scandinavian Journal of Urology and Nephrology. 52-64.
  • Show author(s) (2013). Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma. Scandinavian Journal of Urology and Nephrology. 462-471.
  • Show author(s) (2013). Expression of apoptosis associated proteins Survivin, Livin and Thrombospondin-1 in Burkitt lymphoma. APMIS - Journal of Pathologiy, Microbiology and Immunology. 239-245.
  • Show author(s) (2013). Diagnostic yield of biopsies of cervical lymph nodes using a large (14-gauge) core biopsy needle. APMIS - Journal of Pathologiy, Microbiology and Immunology. 1119-1130.
  • Show author(s) (2013). Agalsidase Benefits Renal Histology in Young Patients with Fabry Disease. Journal of the American Society of Nephrology. 137-148.
  • Show author(s) (2012). Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010. American Society of Nephrology. Clinical Journal. 1591-1597.
  • Show author(s) (2012). Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma. Scandinavian Journal of Urology and Nephrology. 348-357.
  • Show author(s) (2012). Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort. Nephrology, Dialysis and Transplantation. 1485-1491.
  • Show author(s) (2011). The RB (pRb2/p16) and p53 (p14/p53/p21) Tumor-suppressor Pathways in Endemic Burkitt Lymphoma. Journal of Pediatric Hematology/Oncology. E54-E59.
  • Show author(s) (2011). Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney International. 663-670.
  • Show author(s) (2011). Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients. Clinical Transplantation. E356-E365.
  • Show author(s) (2010). Thrombotic microangiopathy and the antiphospholipid syndrome. Lupus. 1569-1572.
  • Show author(s) (2010). The activity of pregnancy-associated plasma protein A (PAPP-A) as expressed by immunohistochemistry in atherothrombotic plaques obtained by aspiration thrombectomy in patients presenting with a ST-elevation myocardial infarction: a brief communication. Thrombosis Journal.
  • Show author(s) (2010). Scoring system for renal pathology in Fabry disease: Report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrology, Dialysis and Transplantation. 2168-2177.
  • Show author(s) (2010). Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease. Nephrology, Dialysis and Transplantation. 3289-3296.
  • Show author(s) (2009). pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda. BMC Clinical Pathology.
  • Show author(s) (2009). The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival. Journal of Urology. 2144-2149.
  • Show author(s) (2009). Reactive lymphadenopathy in Ugandan patients and its relationship to EBV and HIV infection. APMIS - Journal of Pathologiy, Microbiology and Immunology. 302-307.
  • Show author(s) (2009). Observation should be considered as an alternative in management of renal masses in lder and comorbid patients. European Urology. 1419-1429.
  • Show author(s) (2009). Lymphomas diagnosed in Uganda during the HIB/AIDS pandemic. East African Medical Journal. 226-32.
  • Show author(s) (2008). The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomy. BMC Urology.
  • Show author(s) (2008). Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. American Journal of Kidney Diseases. 767-776.
  • Show author(s) (2008). Organ-confined clear cell renal cell carcinoma: the prognostic impact of microvascular invasion, nuclear grade and tumour size. APMIS - Journal of Pathologiy, Microbiology and Immunology. 1027-1033.
  • Show author(s) (2007). Renal cell carcinoma: A clinicopathological follow-up study after radical nephrectomy. Scandinavian Journal of Urology and Nephrology. 191-197.
  • Show author(s) (2007). Long-term risk of cancer in membranous nephropathy patients. American Journal of Kidney Diseases. 396-403.
  • Show author(s) (2006). Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 277-284.
  • Show author(s) (2006). Adverse perinatal outcome and later kidney biopsy in the mother. Journal of the American Society of Nephrology. 837-845.
  • Show author(s) (2005). Focal and segmental glomerular sclerosis (FSGS) in a man and a woman with Fabry's disease. Clinical Nephrology. 394-401.
  • Show author(s) (2004). Co-occurrence of Epstein-Barr virus infection and ascites in sarcoidosis. Scandinavian Journal of Infectious Diseases. 232-234.
  • Show author(s) (2004). Bedside stereomicroscopy of renal biopsies may lead to a rapid diagnosis of Fabry's disease. Nephrology, Dialysis and Transplantation. 3202-3203.
  • Show author(s) (2003). Role of angiotensin II under prolonged increased intraabdominal pressure (IAP) in pigs. Surgical Endoscopy. 1092-1097.
  • Show author(s) (2003). Enlarged nephrons and severe non-diabetic nephropathy in hepatocyte nuclear factor (HNF)-1 beta mutation carriers. Kidney International. 793-800.
  • Show author(s) (2003). Enlarged nephrons and severe non-diabetic nephropathy in hepatocyte nuclear factor (HNF)-1 beta mutation carriers. Kidney International. 793-800.
  • Show author(s) (2003). Effects of the endothelin-1 receptor antagonist Tezosentan on renal blood flow and diuresis during prolonged increased intra-abdominal pressure. Journal of Surgical Research. 33-40.
  • Show author(s) (2003). Clinical prognostic factors in biopsy-proven benign nephrosclerosis. Nephrology, Dialysis and Transplantation. 517-523.
  • Show author(s) (2002). Prognostic factors in mesangioproliferative glomerulonephritis. Nephrology, Dialysis and Transplantation. 1603-1613.
  • Show author(s) (2002). Clinical outcome in patients with Wegners granulomatosis treated with plasmapheresis. Blood Purification. 167-173.
  • Show author(s) (2001). Wegners ganulomatosis: Inflammatory cells and markers of repair and fibrosis in renal biopsies. A clinicopathological study. Scandinavian Journal of Urology and Nephrology. 401-410.
  • Show author(s) (2001). Renal histopathology and clinical course in 94 patients with Wegners granulomatosis. Nephrology, Dialysis and Transplantation. 953-960.
  • Show author(s) (2001). Diagnostic transmission electron microscopy. Tidsskrift for Den norske legeforening. 576-580.
  • Show author(s) (2000). Wegener's granulomatosis: clinical course in 108 patients with renal involvement. Nephrology, Dialysis and Transplantation. 611-18.
  • Show author(s) (2000). Changes in tonsillar tissue in early HIV-1 infection and during 3 years of antiretroviral therapy. APMIS - Journal of Pathologiy, Microbiology and Immunology. 539-550.
  • Show author(s) (1999). Nyrebiopsier og videokonferanser. Tidsskrift for Den norske legeforening. 3172-3173.
  • Show author(s) (1999). Nyrebiopsier og videokonferanser. Tidsskrift for Den norske legeforening. 3172-73.
  • Show author(s) (1999). Microscopic polyangiitis diagnosed at hysterectomy. Clinical and Experimental Rheumatology. 611-13.
  • Show author(s) (1999). A novel syndrome of diabetes mellitus, renal dysfunction and genital malforation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta. Human Molecular Genetics. 2001-2008.
  • Show author(s) (1997). Correlates of latent and productive HIV type-1 infection in tonsillar CD4 (+) T cells. Proceedings of the National Academy of Sciences of the United States of America. 9332-6.
  • Show author(s) (1997). Autoregulation of total and zonal glomerular filtration rate in spontaneously hypertensive rats with mesangiolysis. Kidney and Blood Pressure Research. 11-17.
  • Show author(s) (1997). Autoregulation of total and zonal glomerular filtration rate in spontaneously hypertensive rats with mesangiolysis. Kidney and Blood Pressure Research. 11-17.
  • Show author(s) (1994). Renal effects of maintenance low-dose cyclosporin A treatment in psoriasis. Nephrology, Dialysis and Transplantation. 1462-1467.
Academic lecture
  • Show author(s) (2012). Radiologisk vs. patologisk størrelse av nyrecellecarcinomer i stadium I og II - betydning for stadiumspesifikk overlevelse.
  • Show author(s) (2012). Evaluering av oppfølgningsprogrammet for nyrekreft (RCC)ved Haukeland universitetssjukehus.
  • Show author(s) (2010). 5 YEARS FOLLOW-UP RENAL BIOPSIES IN PAEDIATRIC AND ADULT FABRY PATIENTS ON ENZYME REPLACEMENT THERAPY.
  • Show author(s) (2007). The role of thrombospondin-1 in angiogenesis and patients survival after radical nephrectomy for clear cell renal cell carcinoma.
  • Show author(s) (2007). The independent impact of microvessel density in low-stage clear cell renal cell carcinoma after radical nephrectomy.
  • Show author(s) (2006). Diagnostiske intracellulære krystaller i urinen.
Reader opinion piece
  • Show author(s) (2012). En mann i 50-årene med feber, hoste og anuri. Tidsskrift for Den norske legeforening. 1621-1624.
  • Show author(s) (2011). Fabry or not Fabry – a question of ascertainment. European Journal of Human Genetics. 1111-1112.
Non-fiction book
  • Show author(s) (2001). Veileder i biopsibesvarelse av maligne svulster. Den norske lægeforening.
  • Show author(s) (2001). Kvalitetssikring i spesialiteten patologi. Den norske lægeforening.
Doctoral dissertation
  • Show author(s) (2018). A population based study on Kidney Cancer in Norway (2008 - 2013).
Abstract
  • Show author(s) (2013). Serum VEGF in patients with renal tumours and low contrast enhancement on ct can be used to predict survival and recurrence. Scandinavian Journal of Urology and Nephrology. 32-33.
  • Show author(s) (2012). VALIDATION OF FRENCH MODEL TO PREDICT ESRD AND DEATH IN IGA NEPHROPATHY PATIENTS. Nephrology, Dialysis and Transplantation. 189-190.
  • Show author(s) (2012). STANDARDIZED MORTALITY RATE IN IGA NEPHROPATHY PATIENTS. Nephrology, Dialysis and Transplantation. 188-188.
  • Show author(s) (2010). SCORING SYSTEM FOR RENAL PATHOLOGY IN FABRY DISEASE: REPORT OF THE INTERNATIONAL STUDY GROUP OF FABRY NEPHROPATHY (ISGFN). Clinical Therapeutics. S105-S105.
  • Show author(s) (2010). RENAL FOLLOW-UP BIOPSIES IN YOUNG MALE FABRY PATIENTS ON ENZYME REPLACEMENT THERAPY. Clinical Therapeutics. S105-S107.
  • Show author(s) (2010). Natural history and structural-functional relationships (SFR) in Fabry nephropathy (FN). Molecular Genetics and Metabolism. S27-S28.
  • Show author(s) (2009). Fabry Disease: Unusual Symptoms in two Boys Treated with Lamotrigine and Fabrazyme, Respectively. Clinical Therapeutics. S43-S43.
  • Show author(s) (2008). Prominence of glomerular and vascular changes in renal biopsies in children and adolescents with Fabry disease and microalbuminuria. Clinical Therapeutics. S42-S42.
Poster
  • Show author(s) (2009). Renal follow-up biopsies in young male Fabry patients on enzyme replacement therapy.
  • Show author(s) (2008). Renal biopsies in children in Norway 1988-2005: clinical variables, complications and prognosis.
  • Show author(s) (2008). Fabry disease: Unusual symptoms in two male children treated with lamotrigine and fabrazyme, respectively.
  • Show author(s) (2006). Cathepsin B and Cystatin A as indicators of a separate apoptotic pathway in HIV-1 infection.
  • Show author(s) (2005). Glomerular and vascular changes are prominent in renal biopsies in children and adolescents with Fabry disease and microalbuminuria.
  • Show author(s) (2005). Cathepsin B and Cystatin A as indicators of a separate apoptotic pathway in HIV-1 infection.
  • Show author(s) (2004). Early signs of focal and segmental glomerulosclerosis (FSGS) and arteriolopathy is prevalent in Fabry patients with minimal proteinuria or slightly reduced GFR.
  • Show author(s) (2003). Perinatal factors and later kidney disease as diagnosed by kidney biopsy.
Errata
  • Show author(s) (2021). Corrigendum to “The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma” [Cytokine 144 (2021) 155586](S1043466621001691)(10.1016/j.cyto.2021.155586). Cytokine.

More information in national current research information system (CRIStin)